Cite

HARVARD Citation

    Couturier, M. et al. (2021). Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults. Leukemia & lymphoma. 62 (3), pp. 620-629. [Online]. 
  
Back to record